Vitamin D and Hair Loss: Correlation, Causation, or Supplement Marketing?

Vitamin D testing has become a routine component of hair loss workups, driven by observational studies showing associations between low serum 25-hydroxyvitamin D (25(OH)D) levels and various hair loss conditions — including alopecia areata, telogen effluvium, and androgenetic alopecia. The supplement industry has amplified these associations into causal claims, marketing vitamin D supplementation as a treatment for hair loss.

The mechanistic rationale is plausible: vitamin D receptors (VDR) are expressed in hair follicle keratinocytes, and VDR knockout mouse models develop alopecia — demonstrating that VDR signaling is required for normal hair cycling. However, the mouse model involves complete VDR absence, not the modest deficiency seen in humans with low-normal vitamin D levels. The translation from VDR knockout phenotype to clinical vitamin D supplementation benefit is not straightforward.

This analysis examines the observational evidence linking vitamin D to hair loss, the mechanistic evidence for VDR involvement in hair cycling, and the limited intervention trial data on vitamin D supplementation for hair loss outcomes.

The Observational Evidence: Association Without Causation

The observational literature on vitamin D and hair loss is consistent in showing associations but limited in establishing causation. A 2019 systematic review by Almohanna and colleagues identified multiple cross-sectional studies finding lower mean 25(OH)D levels in patients with alopecia areata (AA), telogen effluvium (TE), and female pattern hair loss (FPHL) compared to healthy controls. The associations were statistically significant in most studies, with mean 25(OH)D levels in hair loss patients typically 5–15 ng/mL lower than controls.

However, cross-sectional associations cannot establish causation. Several confounders could explain the association without a causal relationship: patients with hair loss may have underlying conditions (autoimmune disease, thyroid dysfunction, nutritional deficiencies) that independently cause both hair loss and vitamin D deficiency; patients with hair loss may have reduced outdoor activity (and therefore reduced sun exposure) due to self-consciousness; and the association may reflect reverse causation (hair loss causing behavioral changes that reduce vitamin D synthesis).

The alopecia areata association is the most studied and most consistent. AA is an autoimmune condition, and vitamin D has immunomodulatory properties — the mechanistic link is more plausible for AA than for androgenetic alopecia, which is primarily androgen-driven. Several studies have found inverse correlations between 25(OH)D levels and AA severity, but causation remains unestablished.

Clinical Implications: When Testing and Supplementation Are Warranted

The evidence supports vitamin D testing as part of a hair loss workup — not because deficiency is a leading cause of hair loss, but because deficiency is common in the general population, is associated with hair loss conditions, and is easily correctable. Correction of documented deficiency (25(OH)D below 20 ng/mL) is appropriate regardless of hair loss status.

The evidence does not support supplementation in vitamin D-sufficient individuals for hair loss outcomes. The "optimal levels" framing in supplement marketing — implying that levels above the deficiency threshold but below some higher "optimal" level cause hair loss — is not supported by the intervention trial data.